Johnson & Johnson rolls out mobile training centre for surgeons

New Delhi, Medical devices maker Johnson & Johnson Medical India on Thursday launched a specialised bus to travel across the country and provide hands on surgery training to around 25,000 healthcare professionals in the next five years.

Named “Johnson & Johnson Institute on Wheels”, this mobile training centre would enhance “the surgical skills of doctors, nurses, and para medical staff to address the demands of today’s health care delivery system and provide better outcomes to patients of India,” the company said in a statement.

“With the launch of the Johnson & Johnson Institute on Wheels, we hope to train 25,000 surgeons across 400 towns in the next five years,” said Sushobhan Dasgupta, Managing Director, Johnson and Johnson Medical India.

It will travel to various medical colleges and teaching hospitals across the country to train budding and practicing surgeons and para medical staff.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Mankind Pharma to Acquire 70% Stake in Belgium’s ACTx

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    Can a drug licence be suspended before a hearing? Karnataka HC explains rule

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    A Boy survives 18th Floor Fall, thanks to Yashoda Medicity

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    AstraZeneca, NIPER Raebareli partner to upgrade 25 clinical trail sites

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    FDA clears ImmunityBio’s Anktiva expansion in bladder cancer after regulatory whiplash

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs

    Sun Pharma Approves Rs 10,000 Crore Fundraising Through NCDs